Court Opinion

ID: 9901979
Source: CourtListenerOpinion
Date Created: 2023-11-22 19:02:23.893856+00
Date Added: 2024-06-11T09:21:42.510121
License: Public Domain

Filed 11/22/23 Hassan v. Quantum3D CA6
                      NOT TO BE PUBLISHED IN OFFICIAL REPORTS
California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for
publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication
or ordered published for purposes of rule 8.1115.

                IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

                                      SIXTH APPELLATE DISTRICT

 KAZI HASSAN et al.,                                                 H050403
                                                                    (Santa Clara County
           Plaintiffs and Appellants,                                Super. Ct. No. 19CV360269)

           v.

 QUANTUM3D, INC.,

           Defendant and Respondent.

                                              I. INTRODUCTION
         Plaintiffs and appellants Kazi Hassan and Sisigma, Inc. (Sisigma) brought an
action against defendant and respondent Quantum3D, Inc. (Quantum) and defendant
Murat Kose alleging that they breached an oral agreement whereby plaintiffs would
provide various services to Quantum in order to turn the company around in exchange for
compensation that allegedly included 30 percent of Quantum’s gross revenues. The trial
court sustained defendants’ demurrers to the causes of action in the second amended
complaint without leave to amend on the grounds of the sham pleading doctrine, which
provides that where a complaint is amended to omit harmful allegations that render a
cause of action defective, the trial court may disregard the new and contrary allegations
in the amended complaint. (See Hendy v. Losse (1991) 54 Cal.3d 723, 742–743
(Hendy).)
       On appeal, Hassan and Sisigma argue that the trial court erred because the sham
pleading doctrine does not apply to bar their claims. For the reasons stated below, we
conclude that the trial court properly sustained the demurrers without leave to amend as
to all causes of action remaining in the second amended complaint with the exception of
the fifth cause of action labeled unjust enrichment. We will therefore direct the trial court
(1) to vacate the order sustaining the demurrers to the first through fifth and seventh
through ninth causes of action of the second amended complaint without leave to amend;
and (2) to enter a new order sustaining the demurrer without leave to amend as to the first
through fourth causes and the seventh through ninth causes of action and overruling the
demurrer as to the fifth cause of action.
                                    II. BACKGROUND
       A. Original Complaint
       In the original complaint, plaintiff Hassan described himself as “an accomplished
engineer and entrepreneur with 25 years[ of] experience in the technology industry.”
Hassan is the founder and principal of plaintiff Sisigma, a California corporation.
       Plaintiffs alleged as follows regarding defendants Quantum and Kose.1 Quantum
is a Delaware corporation that is “a wholly-owned subsidiary of Havelsan, which is
owned by the Turkish Armed Forces Foundation.” Plaintiffs asserted that Kose and
Quantum were agents of each other and acted within the scope of their agency.
       Hassan was initially contacted by Kose on August 13, 2017, when Kose
telephoned Hassan stating he was “working with a Turkish-owned Silicon Valley
software company” and wanted to connect with technology leaders. Hassan and Kose
then met at Quantum’s headquarters on August 15, 2017. During the meeting, Kose
informed Hassan that Quantum was losing money and he had been engaged to turn the
company around. Kose stated that the “Turkish government did not know what to do

       1
           Defendant Kose is not a party to this appeal.

                                               2
with QUANTUM and that he had not yet been formally hired by QUANTUM.” Kose
also told Hassan that Sisigma’s KnotSuite application could be marketed and sold in
Turkey. Hassan was introduced by Kose to Dr. Abdullah Cavusoglu, the chairman of
Havelsan’s board of directors, and several Quantum company officers.
      A day later, on August 16, 2017, Kose and Cavusoglu went to Hassan’s home for
a dinner meeting. During the meeting, they asked Hassan to help turn Quantum around
because Kose lacked experience in running a company. At that time, Kose was not
employed by Quantum and “was acting in his individual capacity.” Kose and Cavusoglu
also said “they did not yet have control over QUANTUM, so they could not officially
engage [Hassan and Sisigma]. KOSE and Cavusoglu asked HASSAN to instruct, guide
and train KOSE from behind the scene, promising compensation and revenue sharing
once they gained control the company.” Kose and Cavusoglu “reiterated they could not
formalize anything with [Hassan and Sisigma] until they first gained control of
QUANTUM.”
      Kose and Cavusoglu also “promised that, once they assumed control of
QUANTUM, HASSAN would receive a director position within Havelsan and a business
relationship between QUANTUM, Havelsan and SISIGMA would be formalized.” Kose
and Cavusoglu “represented to HASSAN that, upon KOSE’s assumption of leadership at
QUANTUM, which they estimated would occur within six months, three promises would
be formalized: (1) HASSAN would be appointed to Havelsan’s board of directors;
(2) QUANTUM would become a partner and customer of SISIGMA and they would
engage new customers in Turkey, with 70% revenue going to QUANTUM and 30%
revenue going to SISIGMA; and (3) [Hassan and Sisigma] would be recognized for their
work from the outset. Details of the partnership agreement would be refined as the
parties continued working together.”
      Thereafter, Hassan performed work for Quantum that included restructuring the
management team, executing a technology transfer project, training Kose, fixing a toxic

                                            3
culture, dissuading Quantum from implementing a wasteful internal product plan,
revitalizing Quantum’s existing product, developing a new product strategy, formulating
a plan to solve Quantum’s customer acquisition problem, instructing Kose on which
projects to pursue or abandon, and devising initiatives to increase customers for existing
products.
       In October 2017 Kose and Hassan had a meeting in which they agreed to form a
new corporation named KnotReal, in which Quantum would have 70 percent of the
company’s shares and Sisigma would have 30 percent, and Havelsan would invest $15
million. Hassan developed partnership agreements in collaboration with Kose, which he
emailed to Kose and Cavasoglu in November 2017. However, Kose responded by
feigning ignorance of the terms of their agreement. On November 25, 2017, Kose
informed Hassan that he had been appointed CEO of Quantum and asked Hassan for his
help with an upcoming trade show. Hassan continued to assist Kose in reliance on
Kose’s previous promises.
       In December 2017 Hassan asked Kose for an update, and Kose responded that he
was trying “ ‘to finalize [a] tech transfer.’ ” Hassan then discovered that Quantum was
using and marketing the ideas of Hassan and Sisigma in violation of their agreements.
After Hassan told Kose that he was not allowed to use his ideas, Kose ceased all
communications with Hassan while retaining the benefits of his work.
       Based on these allegations, the original complaint included a cause of action for
breach of oral contract, which stated: “As of August 2017, KOSE was not yet employed
by QUANTUM. Accordingly, KOSE was acting in his individual capacity. After
KOSE’s employment formally commenced with QUANTUM, particularly after he was
elevated to CEO on or about November 25, 2017, QUANTUM was the beneficiary of
[Hassan’s] industry, and because its CEO knew it was receiving services from [Hassan
and Sisigma], QUANTUM effectively ratified and/or affirmed the oral agreement. After
becoming CEO of QUANTUM, KOSE acted on QUANTUM’s behalf in all dealings

                                             4
with [Hassan and Sisigma]. [¶] In the alternative, because KOSE and HASSAN
negotiated contract terms in front of Cavusoglu, the chairman of the board of Havelsan,
QUANTUM’s sole or majority shareholder, KOSE had ostensible authority to bind
QUANTUM.”
       The original complaint also included causes of action for promissory estoppel,
unjust enrichment, breach of confidential relationship, trade secret misappropriation,
fraud, and violation of Business and Professions Code section 17200.
       After defense counsel sent plaintiffs’ counsel a meet and confer letter (Code Civ.
Proc., § 430.41 [requirement to meet and confer prior to filing demurrer]), plaintiffs
obtained new counsel and filed a first amended complaint.
       B. First Amended Complaint
       The first amended complaint included several allegations that were different from
the allegations of the original complaint. Significantly, the first amended complaint
expressly alleged that Kose and Quantum had formed a joint venture with Hassan and
Sisigma and that Kose was the agent of Quantum. Plaintiffs also alleged that in August
2017 Kose and Cavasoglu “claimed that they had complete authority over [Quantum] and
had the power to bind it to legal agreements and commitments.” According to plaintiffs,
Kose and Cavasoglu said that they had this authority because Havelsan owned Quantum,
Cavasoglu was Havelsan’s chairman, and Kose was Quantum’s agent “to obtain the
necessary resources to effect a turnaround at [Quantum].” However, Kose and Cavasoglu
also stated that they lacked “practical control” over Quantum and “requested that the joint
venture’s work be kept secret until they achieved certain business objectives.”
       The first amended complaint further alleged that the terms of the parties’ oral
agreement to form a joint venture included contributions by a division of Sisigma,
KnotReal, and contributions by Quantum. KnotReal, through Hassan, would analyze
Quantum’s management, operations, and culture, reinvent Quantum’s product strategy,
and adopt new business strategies to make Quantum a high performing business.

                                             5
Quantum would cooperate in these efforts and give KnotReal 30 percent of Quantum’s
gross revenue.
      Kose allegedly became a “Liaison Officer” for Quantum in August 2017 and
began implementing some of Hassan’s recommendations. Hassan performed work to
turn Quantum around similar to the work alleged in the original complaint. However,
Kose and Cavasoglu did not want to make the parties’ joint venture public until certain
milestones were met in Quantum’s turnaround, including Kose being appointed CEO.
Once these milestones were met, Kose and Cavasoglu promised that Hassan would be
made a director of Havelsan, Havelsan would promote Sisigma in Turkey, and Havelsan
would make an immediate investment in KnotReal and a multi-million dollar investment
at a later date. Relying on these promises, Hassan abandoned his plan to market
Sisigma’s KnotSuite application in Bangladesh and redirected Sisigma’s efforts to the
market in Turkey.
      In November 2017 Kose told Hassan that he had been appointed CEO of
Quantum, and requested Hassan’s assistance with an upcoming trade show. In
December 2017 Kose told Hassan that Cavasoglu had left Havelson. Although Kose
wanted Hassan to remain involved with Quantum, Kose said Hassan’s contributions
could not yet be publicly announced. Kose also told Hassan that he could outsource in
Bangladesh, and Hassan responded that he did not do outsourcing and requested an in-
person meeting regarding Kose’s promises and commitments. When Kose replied that he
was too busy to meet, Hassan checked Quantum’s Twitter account and discovered that
Quantum was using plaintiffs’ work product. Hassan notified Kose that Quantum could
not use plaintiffs’ work product without honoring its commitments. Thereafter, Kose
ceased all communications with Hassan. Hassan believes that Havelsan has implemented
a version of Sisigma’s KnotSuite application.
      Based on these and other allegations, the first amended complaint includes causes
of actions for (1) breach of oral joint venture agreement between Sisigma and Quantum;

                                            6
(2) breach of implied in fact contract between Sisigma and Quantum; (3) fraud;
(4) negligent misrepresentation; (5) unjust enrichment; (6) trade secret misappropriation;
(7) breach of joint venture; (8) breach of partnership; (9) breach of fiduciary duty; and
(10) violation of Business and Professions Code section 17200.
       C. Demurrer to First Amended Complain
       Defendants Kose and Quantum demurred to the first amended complaint on the
grounds that none of the causes of action stated facts sufficient to constitute a cause of
action. Specifically, defendants argued that all causes of action, with the exception of the
fifth cause of action for unjust enrichment and the sixth cause of action for trade secret
misappropriation, were barred under the sham pleading doctrine due to plaintiffs’
inconsistent allegations regarding agency and the terms of the alleged agreements.2 The
demurrers did not address the tenth cause of action for violation of Business and
Professions Code section 17200.
       In their memorandum of points and authorities, defendants asserted that key
allegations regarding agency were inconsistent, including the allegations in the original
complaint that Kose and Cavasoglu advised Hassan during the August 2017 meeting that
they did not have authority to bind Quantum, which conflicted with the allegations in the
first amended complaint that Kose and Cavasoglu had complete authority over Quantum
and the power to bind it to legal agreements.
       Further, defendants pointed out that the original complaint and the first amended
complaint alleged different terms for the parties’ purported agreements with respect to the
compensation that plaintiffs would receive from Quantum in exchange for providing
turnaround services. The original complaint alleged that Hassan would be appointed to
Havelsan’s board of directors, Sisigma would receive 30 percent of the revenue from new

       2
         The record reflects that plaintiffs have dismissed the sixth cause of action for
trade secret misappropriation with prejudice. We therefore need not further address this
cause of action in the present appeal.

                                              7
customers in Turkey of a partnership between Quantum and Sisigma, and plaintiffs’
work would be recognized from the outset. In contrast, defendants noted, the first
amended complaint alleged that plaintiffs’ compensation would include Sisigma
receiving 30 percent of Quantum’s revenue, Havelsan would market Sisigma’s KnotSuite
application in Turkey, and recognition of plaintiffs’ work would not be immediately
announced.
       Defendants argued that under the sham pleading doctrine, plaintiffs could not cure
the defects in the original complaint by pleading inconsistent facts in the first amended
complaint without explanation. Since plaintiffs had alleged in the original complaint that
Kose and Cavasoglu advised them during the August 2017 meeting that they did not have
authority to bind Quantum, defendants contended that no oral agreement with Quantum
was formed during the August 2017 meeting and the inconsistent allegations in the first
amended complaint regarding their authority to bind Quantum must be disregarded.
Defendants also maintained that the inconsistent allegations regarding the terms of the
alleged agreement with Quantum showed that no contract was formed in the absence of
the parties’ agreement regarding the material terms. Accordingly, defendants argued that
their demurrers to the first cause of action for breach of oral joint venture agreement and
the second cause of action for breach of implied contract should be sustained without
leave to amend. For the same reasons, defendants maintained that plaintiffs could not
state either the seventh cause of action for breach of joint venture agreement, the eighth
cause of action for breach of partnership agreement, or the ninth cause of action for
breach of fiduciary duty.
       Defendants also argued that inconsistent allegations regarding the authority of
Kose and Cavasoglu to bind Quantum were fatal to the third cause of action for fraud and
the fourth cause of action for negligent misrepresentation under the sham pleading
doctrine. Defendants explained that when the inconsistent allegations of the first

                                             8
amended complaint regarding agency were disregarded, plaintiffs failed to allege that any
representations were made by an agent of Quantum.
       As to the fifth cause of action for unjust enrichment, defendants asserted that
unjust enrichment is not an independent cause of action.
       Plaintiffs opposed the demurrers to the first amended complaint, contending that
the sham pleading doctrine did not apply to bar their claims. They maintained that the
first amended complaint properly clarified inartful pleading by prior counsel in the
original complaint regarding the control and authority that Kose and Cavasoglu exerted
over Quantum. Alternatively, plaintiffs argued that the allegations in the original
complaint were sufficient to show that Kose had ostensible authority to bind Quantum,
since it was alleged that Kose had negotiated the parties’ agreement in the presence of
Cavasoglu, the chairman of Havelsan, Quantum’s corporate parent. Plaintiffs also argued
that the allegations of the original complaint were sufficient to show that the parties’
agreement was ratified by Quantum accepting the benefits of the agreement that Kose
had negotiated. As to the claim that the allegations were inconsistent with respect to the
terms of the parties’ agreement, plaintiffs responded that the allegations of the first
amended complaint superseded the allegations of the original complaint. Accordingly,
plaintiffs argued that the demurrers to the first amended complaint should be overruled.
       D. Order Sustaining Demurrer to First Amended Complaint
       In the February 25, 2022 order, the trial court sustained the demurrers to the first
amended complaint with leave to amend as to defendant Quantum and overruled the
demurrers as to defendant Kose. The court agreed with defendants that original
complaint alleged that Kose and Cavasoglu lacked authority to enter into agreements on
behalf of Quantum, and that the inconsistent allegations in the first amended complaint
regarding their authority should be disregarded under the sham pleading doctrine. The
court further agreed that the inconsistent allegations regarding the terms of the parties’
agreement, including whether the parties had entered into a partnership or a joint venture,

                                              9
precluded a sufficient allegation of contract formation. The court therefore granted
plaintiffs leave to amend the first amended complaint to explain the inconsistencies.
       E. Second Amended Complaint
       The second amended complaint essentially restated the factual allegations of the
first amended complaint and included the same 10 causes of action as the first amended
complaint. However, the second amended complaint included several new paragraphs
captioned “Explanation Of Inconsistencies Between Second Amended Complaint And
Original Complaint.” (Capitalization and underline omitted.) In their explanation,
plaintiffs acknowledged that there were certain inconsistencies in the allegations in the
original complaint and the first amended complaint, but explained that the allegations of
the first amended complaint were correct and clarified any ambiguities.
       Plaintiffs further explained that the inconsistent allegations were due to their first
attorney, who was based in San Diego, preparing the original complaint in “extreme
haste” and communicating in writing or by phone, with no in-person meeting with
plaintiffs. Plaintiffs additionally stated that they had only three days to review the
complaint and did not review the final version that was filed 10 days after the first
attorney was retained. Also, Hassan asserted that English is his second language and he
understood the word “control” in the original complaint’s allegations to mean only that
Kose and Cavasoglu lacked “practical control.”
       Plaintiffs also stated that they “never meant to convey that KOSE and
CAVOSOGLU stated during the August 2017 meeting that they lacked legal authority to
enter QUANTUM3D into a binding contract. To the contrary, as alleged in this Second
Amended Complaint, KOSE and CAVOSGOLU represented that they had complete
authority to do so but felt that they lacked practical control and needed plaintiffs’ help,
from behind the scenes, in gaining that practical control.” Plaintiffs also asserted that
“[i]n short, the Second Amended Complaint, written with the benefit of new counsel and

                                              10
without the extreme time constraints and resulting communication issues associated with
the Original Complaint, reflects an accurate version of events.”
       F. Demurrer to Second Amended Complaint
       Defendants demurred on the grounds that the causes of action in the second
amended complaint, except the sixth cause of action for trade secret misappropriation,
failed to state facts sufficient for any cause of action under the sham pleading doctrine.
The demurrers did not address the tenth cause of action for violation of Business and
Professions Code section 17200. Defendants argued in their memorandum of points and
authorities that plaintiffs’ explanations of the reasons for the inconsistencies in their
pleading did not overcome the sham pleading doctrine because their explanations were
not plausible, for two reasons.
       First, defendants asserted that plaintiffs’ explanation that their original allegation
that they lacked control over Quantum was clarified in the first amended complaint to
clarify that Kose and Cavasoglu only lacked practical or operational control, and could
bind the company to legal agreements, was not persuasive because the original complaint
also alleged that Kose lacked authority to bind Quantum and was acting in his individual
capacity. Second, defendants argued that plaintiffs’ explanation regarding the haste in
which the original complaint was drafted and filed was not plausible since plaintiffs
failed to specifically explain how the circumstances, such as having only three days to
review the draft complaint, prevented them from correcting any inaccuracies in the
allegations of the original complaint.
       In their opposition to the demurrers, plaintiffs contended that their explanation of
the difficult circumstances that resulted in any inconsistencies in the allegations of the
original and first amended complaint was adequate and did not implicate the sham
pleading doctrine in the absence of dishonest pleading. Alternatively, plaintiffs argued
that even if the allegations that Kose and Cavasoglu stated at the August 2017 meeting
with Hassan that they lacked control of Quantum were disregarded, the second amended

                                              11
complaint sufficiently alleged an implied in fact joint venture agreement and unjust
enrichment on the basis of the allegations that Quantum accepted the benefit of plaintiffs’
performance under the agreement.
       G. Order Sustaining Demurrer and Judgment of Dismissal
       In the July 29, 2002 order the trial court sustained Quantum’s demurrers to the
first through fifth and seventh through ninth causes of action of the second amended
complaint without leave to amend under the sham pleading doctrine.
       Regarding the inconsistent allegations, the trial court determined that “[t]he initial
complaint alleges that Kose and Cavusoglu did not have control over Quantum, Kose was
not employed by Quantum and could not contract on behalf of Quantum or bind Quantum
to a contract until he was employed by Quantum,” and these allegations were inconsistent
with the allegations in the second amended complaint that Kose and Cavasoglu told
Hassan that they had complete authority to bind Quantum to legal agreements.
(Underline omitted.) The court also determined that the allegations regarding the terms
of the parties’ alleged agreement in the original complaint and the second amended
complaint were inconsistent.
       Further, the trial court ruled that plaintiffs’ explanation in the second amended
complaint regarding the reasons for the inconsistences was implausible because plaintiffs
only offered the excuse that they had failed to notice the inaccurate allegations in the
original complaint, and therefore the sham pleading doctrine applied.
       On February 7, 2023, this court ruled as follows regarding the absence of a
judgment of dismissal in the record on appeal: “This court deems the July 29, 2022 order
sustaining the demurrer to the first through fifth and seventh through ninth causes of
action to incorporate a judgment of dismissal of those causes of action in favor of
respondent Quantum3d, such that the August 17, 2022 entry of dismissal of the sixth

                                             12
cause of action served as the final judgment resolving all causes of action against
Quantum3d. [Citation.]”3
                                    III. DISCUSSION
       A. Standard of Review
       On appeal from an order of dismissal after a demurrer is sustained without leave to
amend, our review is de novo. (Committee for Green Foothills v. Santa Clara County
Bd. of Supervisors (2010) 48 Cal.4th 32, 42.) In performing our independent review of
the complaint, we assume the truth of all facts properly pleaded by the plaintiff. (Evans
v. City of Berkeley (2006) 38 Cal.4th 1, 6.) Further, “we give the complaint a reasonable
interpretation, and read it in context.” (Schifando v. City of Los Angeles (2003) 31
Cal.4th 1074, 1081 (Schifando).) But we do not assume the truth of “ ‘ “contentions,
deductions or conclusions of fact or law.” ’ ” (Evans, supra, at p. 6.)
       We also consider matters that may be judicially noticed and facts appearing in any
exhibits attached to the complaint. (Code Civ. Proc., § 430.30, subd. (a); Schifando,
supra, 31 Cal.4th at p. 1081.) After reviewing the allegations of the complaint, the
complaint’s exhibits, and the matters properly subject to judicial notice, we exercise our
independent judgment as to whether the complaint states a cause of action as a matter of
law. (See Moore v. Regents of University of California (1990) 51 Cal.3d 120, 125.) In
doing so, we are mindful that “[i]n the construction of a pleading, for the purpose of
determining its effect, its allegations must be liberally construed, with a view to
substantial justice between the parties.” (Code Civ. Proc., § 452.)

       3
         Defendants did not demur to the tenth cause of action for violation of Business
and Professions Code section 17200 and plaintiffs did not address the tenth cause of
action in the proceedings below or object to this court’s entry of a judgment of dismissal.
We therefore deem any issue arising from the tenth cause of action for violation of
Business and Professions Code section 17200 to be forfeited. (See Children's Hospital &
Medical Center v. Bonta (2002) 97 Cal.App.4th 740, 776.)

                                             13
       B. Analysis
              1. Contract Causes of Action
       The second amended complaint includes a first cause of action for breach of oral
joint venture agreement between Sisigma and Quantum and a second cause of action for
breach of implied in fact joint venture agreement between Sisigma and Quantum. In both
contract causes of action, plaintiff Sisigma alleges that it entered into an oral joint venture
agreement with Quantum in August 2017, that Kose was Quantum’s agent authorized to
enter into the agreement on Quantum’s behalf, and that the terms of the agreement were
that Sisigma would provide contributions to Quantum to turn the company around, and in
return Quantum would give Sisigma 30 percent of its gross revenue.
       According to the allegations of the second amended complaint, Sisigma performed
under the joint venture agreement and Quantum breached the agreement by failing to
give Sisigma 30 percent of its gross revenue. The trial court sustained defendants’
demurrers to the contract causes of action without leave to amend under the sham
pleading doctrine due the inconsistencies in the pleading of agency and the terms of the
contract between the original complaint and the second amended complaint.
              2. The Parties’ Contentions
       On appeal, plaintiffs argue that the trial court erred in granting defendants’
demurrers without leave to amend on the ground the contract causes of action were
barred under the sham pleading doctrine due to the inconsistent pleading regarding
agency. According to plaintiffs, the original complaint sufficiently alleged the breach of
contract causes of action because it was alleged that Quantum ratified the agreement by
accepting the benefits of Sisigma’s performance of the contract, and ratification does not
require actual agency when the contract is formed.
       Alternatively, plaintiffs argue that the second amended complaint plausibly
explained why the erroneous allegations in the hastily prepared original complaint—that
Kose and Cavasoglu did not have control of Quantum—were appropriately corrected in

                                              14
the amended complaints because Hassan meant to convey that Kose and Cavasoglu
lacked “practical control” of Quantum, not that they lacked authority to enter into a
contract on Quantum’s behalf. Plaintiffs also argue that the different allegations
regarding the terms of the parties’ agreement do not constitute a pleading defect subject
to the sham pleading doctrine, since a plaintiff may correct pleadings by amendment.
       Defendant Quantum responds that plaintiffs failed to offer a plausible explanation
for the inconsistency between the allegation in the original complaint that Kose and
Cavasoglu “ ‘said they did not yet have control over QUANTUM, so they could not
officially engage Plaintiffs’ ” and the allegation in the second amended complaint that
“that they had complete authority over QUANTUM3D and had the power to bind it to
legal agreements and commitments.”
       Quantum asserts that Hassan’s contention that he misunderstood the meaning of
the word “control” in the original complaint is not believable in light of the other
allegations in the original complaint, including the allegations that Kose told Hassan he
had not been hired by Quantum and was acting in his individual capacity, and he could
not expressly contract with plaintiffs until he became CEO of Quantum. These
allegations are also, Quantum argues, fatal to plaintiffs’ contention that they sufficiently
alleged in the original complaint that Kose and Cavasoglu had ostensible authority as
agents to bind Quantum.
       Quantum further asserts that plaintiffs’ explanation for the inconsistent allegations
in the second amended complaint regarding agency and the terms of the alleged
agreement is not plausible. According to Quantum, plaintiffs do not explain how the
hasty preparation of the original complaint prevented them from noticing that the
complaint did not allege that Kose and Cavasoglu had authority to bind Quantum to a
contract or that there were inaccuracies in the allegations of the contract terms.
       We will begin our evaluation of the parties’ contentions with an overview of the
sham pleading doctrine.

                                             15
               3. The Sham Pleading Doctrine
       The California Supreme Court has stated the sham pleading doctrine as follows:
“ ‘ “Where a verified complaint contains allegations destructive of a cause of action, the
defect cannot be cured in subsequently filed pleadings by simply omitting such
allegations without explanation.” [Citations.] “In such a case the original defect infects
the subsequent pleading so as to render it vulnerable to a demurrer.” [Citation.]
However, we have also made it clear that “a party should be allowed to correct a pleading
by omitting an allegation which, it appears, was made as the result of mistake or
inadvertence.” ’ [Citation.] That rule applies even when a complaint is not verified.
[Citation.]” (Hendy, supra, 54 Cal.3d at pp.742–743.)
       In Hendy, the plaintiff initially alleged that that he and the defendant physician
were co-employees, and the trial court sustained defendant’s demurrer on the grounds
that the medical malpractice action was barred by the exclusive remedy of workers’
compensation. (Hendy, supra, 54 Cal.3d at pp. 727-729.) On appeal, the plaintiff argued
that he should be granted leave to amend his complaint to allege that the defendant
physician was an independent contractor and therefore his medical malpractice claim was
not subject to the exclusive remedy rule. The Supreme Court ruled that leave to amend
could not be granted under the sham pleading doctrine, because “[w]hile plaintiff’s
allegation that defendant [physician] was an employee was made on information and
belief he did not suggest to the trial court that a factual basis existed for amendment of
the complaint to allege that defendant [physician] was an independent contractor, and he
has not demonstrated to this court either that the allegation that [defendant] was an
employee was the result of inadvertence or mistake, or that he has since discovered a
factual basis for alleging that [defendant] was an independent contractor. [Citation.]”
(Id. at p. 743.)
       Thus, “[w]hen a plaintiff files an amended complaint, it may not ‘omit harmful
allegations . . . from previous complaints.’ [Citations.] Unless the plaintiff provides a

                                             16
‘plausible’ explanation for dropping the harmful allegations (such as the need to correct a
mistaken allegation or to clarify ambiguous facts), the trial court will take judicial notice
of the harmful allegations and disregard the new and contrary allegations. [Citation.]”
(Smyth v. Berman (2019) 31 Cal.App.5th 183, 195 (Smyth).)
       However, the sham pleading doctrine “ ‘is not intended to prevent honest
complainants from correcting erroneous allegations or prevent the correction of
ambiguous facts.’ [Citation.] Instead ‘the rule must be taken together with its purpose,
which is to prevent [an] amended pleading which is only a sham, when it is apparent
that no cause of action can be stated truthfully.’ [Citations.]” (JPMorgan Chase Bank,
N.A. v. Ward (2019) 33 Cal.App.5th 678, 690-691; see also Zakk v. Diesel (2019)
33 Cal.App.5th 431, 449 [sham pleading doctrine did not apply where amended pleading
merely clarified basis for relief]; Dones v. Life Insurance Co. of North America (2020)
55 Cal.App.5th 665, 688 [sham pleading doctrine did not apply where the amendment did
not alter the fundamental facts upon which plaintiff’s claim was based],)
              4. The Sham Pleading Doctrine Applies to the Contract Causes of
Action
       Having reviewed the original complaint, the first amended complaint, and the
second amended complaint, we determine for several reasons that the sham pleading
doctrine applies, such that when the inconsistent allegations regarding agency in the
second amended complaint are disregarded, plaintiffs have failed to state facts sufficient
for either the first cause of action for breach of oral joint venture agreement or the second
cause of action for breach of implied joint venture agreement.
       First, we agree with the trial court that plaintiffs’ explanation for the inconsistent
allegations regarding whether Kose and Cavasoglu had authority to bind to Quantum to
an agreement whereby Hassan through Sisigma would provide turnaround services to
Quantum in exchange for the specified benefits is implausible. Plaintiffs’ conclusory
allegations that the circumstances in which the original complaint was prepared, which

                                              17
included a distant attorney, limited time to review the draft complaint, and Hassan’s
English as a second language, do not explain why the original complaint failed to
expressly allege that Kose and Cavasoglu represented that they were agents of Quantum
with authority to bind the company to contracts, as subsequently alleged in the second
amended complaint. Plaintiffs have not demonstrated that the allegations in the original
complaint, including that Kose and Cavasoglu told Hassan in the August 2017 meeting
that and they could not formalize any agreement with plaintiff until Kose became CEO,
was the result of inadvertence or mistake in light of Hassan’s alleged presence at the
meeting. (See Hendy, supra, 54 Cal.3d at p. 743.)
       Further, although the original complaint also includes boilerplate allegations that
the parties were agents of each other, those allegations are insufficient. The general rule
is that in reviewing the trial court’s order on a demurrer, “we apply the rule that specific
allegations control general pleadings.” (Gentry v. eBay, Inc. (2002) 99 Cal.App.4th 816,
827.) Here, the more specific allegations in the original complaint that Kose and
Cavasoglu “did not yet have control over QUANTUM, so they could not officially
engage [Hassan and Sisigma]” and Kose and Cavusoglu “reiterated they could not
formalize anything with [Hassan and Sisigma] until they first gained control of
QUANTUM” control over the general boilerplate allegations of agency.
       Accordingly, in performing our review we may disregard the allegations in the
second amended complaint that Kose and Cavasoglu represented that they had complete
authority to bind Quantum, and determine whether the original complaint stated facts
sufficient for the contract causes of action. (See Smyth, supra, 31 Cal.App.5th at p. 195.)
Plaintiffs contend that the original complaint sufficiently alleged contract formation by
ratification, since Quantum allegedly accepted the benefits of plaintiffs’ work to turn
Quantum around. We disagree.
       “Ratification is the voluntary election by a person to adopt in some manner as his
[or her] own an act which was purportedly done on his [or her] behalf by another person,

                                             18
the effect of which, as to some or all persons, is to treat the act as if originally authorized
by him [or her]. [Citations.]” (Rakestraw v. Rodrigues (1972) 8 Cal.3d 67, 73.)
However, as this court has stated, “[w]here a writing is not required, a principal may
ratify an agency ‘by accepting or retaining the benefit of the act, with notice thereof.’
(Civ. Code, § 2310.) But ‘ratification is possible only when the person whose
unauthorized act is to be accepted purported to act as agent for the ratifying party.’
[Citation.] ” (van’t Rood v. County of Santa Clara (2003) 113 Cal.App.4th 549, 571
(van’t Rood).) As we have discussed, the allegations of the original complaint show that
Kose and Cavasoglu did not purport to act as agents for Quantum, instead alleging that
they could not formalize an agreement with Hassan and Sisigma until they gained control
of Quantum and Kose became CEO. Accordingly, the allegations in the original
complaint are insufficient to establish contract formation by ratification.
                5. The Sham Pleading Doctrine Applies to the Fraud and Negligent
Misrepresentation Causes of Action
       In the second amended complaint, plaintiffs similarly allege in the third cause of
action for fraud and the fourth cause of action for negligent misrepresentation that
Sisigma entered into a joint venture agreement with Quantum upon Kose’s
representations that Sisigma would receive various benefits under the agreement,
including 30 percent of Quantum’s gross revenue; that defendants knew or should have
known that Kose’s representations were untrue; and Quantum is liable for either fraud or
misrepresentation because Kose was its actual agent or became Quantum’s agent by
ratification.
       Plaintiffs argue that the trial court erred in sustaining the demurrers to the fraud
and misrepresentation causes of action because both the original complaint and the
second amended complaint allege that Quantum “ratified Kose and Cavusoglu’s words
and conduct” by accepting the benefits of the parties’ contract. Defendants argue to the
contrary that the allegations of the original complaint show that Kose and Cavasoglu

                                              19
advised Hassan during the August 2017 meeting that they were not agents of Quantum,
and accordingly there is no basis for an allegation that Kose and Cavasoglu were
ostensible agents of Quantum. Defendants also note that plaintiffs allege that in
November 2017, after Kose became CEO, he disavowed the alleged agreement.
       “A corporation may be held vicariously liable as a principal for the torts of its
agents. [Citation.]” (Secci v. United Independant Taxi Drivers, Inc. (2017) 8
Cal.App.5th 846, 855.) However, as we have discussed, under the sham pleading
doctrine we disregard the inconsistent allegations of the second amended complaint that
Kose and Cavasoglu were Quantum’s actual agents, and determine whether the
allegations of the original complaint are sufficient to state causes of action for fraud and
negligent misrepresentation. Plaintiffs are correct that a principal may be liable for the
acts of an ostensible agent. (Civ. Code, § 2334; J.L. v. Children's Institute, Inc. (2009)
177 Cal.App.4th 388, 403-404.) “An agency is ostensible when the principal
intentionally, or by want of ordinary care, causes a third person to believe another to be
his agent who is not really employed by him [or her].” (Civ. Code, § 2300.) “Liability
of the principal for the acts of an ostensible agent rests on the doctrine of ‘estoppel,’ the
essential elements of which are representations made by the principal, justifiable reliance
by a third party, and a change of position from such reliance resulting in injury.” (Preis
v. American Indemnity Co. (1990) 220 Cal.App.3d 752, 761.)
       Here, the allegations of the original complaint are insufficient to establish that
Kose and Cavasoglu were ostensible agents of Quantum. We reiterate that “ ‘ratification
is possible only when the person whose unauthorized act is to be accepted purported to
act as agent for the ratifying party.’ [Citation.] ” (van’t Rood, supra, 113 Cal.App.4th at
p. 571.) As we have discussed, the allegations of the original complaint show that Kose
and Cavasoglu did not purport to act as agents for Quantum, instead alleging that they
could not formalize an agreement with Hassan and Sisigma until they gained control of
Quantum and Kose became CEO. Accordingly, the allegations in the original complaint

                                              20
are insufficient to establish that Kose and Cavasoglu were ostensible agents of Quantum
such that Quantum would be liable for fraud and misrepresentation due to their
representations to Hassan, and therefore the trial court did not err in sustaining the
demurrers to the causes of action for fraud and misrepresentation without leave to amend.
              6. Unjust Enrichment
       In the fifth cause of action for unjust enrichment in the second amended
complaint, plaintiffs alleged that Quantum benefited from the “hard work and industry”
of Hassan and Sisigma by making Quantum more competitive and causing it to flourish.
Plaintiffs further allege that “[i]t is inequitable for defendants to have accepted and
retained these benefits from plaintiffs without consideration or payment of their value.”
       Plaintiffs contend that the trial court erred in sustaining the demurrer to the unjust
enrichment cause of action because “[a] claim for unjust enrichment does not require that
Kose and Cavusoglu had control over Quantum3d at the August 16, 2017, meeting
sufficient to bind Quantum3d to a contract.” Defendants respond that unjust enrichment
is not a valid cause of action; alternatively, defendants contend the allegations are
insufficient under an equitable theory because there was no allegation that Quantum
knowingly accepted the benefits of the alleged agreement that Hassan would provide
turnaround services to Quantum.
       This court has determined that “ ‘[u]njust enrichment is not a cause of action,
however, or even a remedy, but rather “ ‘ “a general principle, underlying various legal
doctrines and remedies” ’ . . . . [Citation.] It is synonymous with restitution.” ’
Citation.]” (Rutherford Holdings, LLC v. Plaza Del Rey (2014) 223 Cal. App.4th 221,
231 (Rutherford Holdings).) We may construe the cause of action labeled unjust
enrichment as a quasi-contract claim seeking restitution. (Ibid.) “ ‘Quasi-contracts,
unlike true contracts, are not based on the apparent intention of the parties to undertake
the performances in question, nor are they promises. They are obligations created by law
for reasons of justice.’ [Citation.] Quasi contractual recovery is based upon benefit

                                             21
accepted or derived for which the law implies an obligation to pay.” (Weitzenkorn v.
Lesser (1953) 40 Cal.2d 778, 794.)
       Thus, “ ‘[a]n individual is required to make restitution if he or she is unjustly
enriched at the expense of another. [Citations.] A person is enriched if the person
receives a benefit at another’s expense. [Citation.]’ [Citations.] ‘The fact that one
person benefits another is not, by itself, sufficient to require restitution. The person
receiving the benefit is required to make restitution only if the circumstances are such
that, as between the two individuals, it is unjust for the person to retain it.’ [Citations.]”
(Welborne v. Ryman-Carroll Foundation (2018) 22 Cal.App.5th 719, 725.)
       In the present case, plaintiffs allege in the second amended complaint that they
provided various types of services to Quantum, such as restructuring the management
team and training Kose to become CEO of Quantum, that benefited the company by
making it successful. Our standard of review requires us to liberally construe these
allegations “with a view to substantial justice between the parties.” (Code Civ. Proc.,
§ 452.) Accordingly, we determine that the fifth cause of action labeled “unjust
enrichment” states facts sufficient for a cause of action in quasi-contract seeking
restitution, and the trial court erred in sustaining the demurrer to the fifth cause of action
without leave to amend. (See Rutherford Holdings, supra, 223 Cal. App.4th at p. 231.)
We will therefore direct the trial court to enter a new order that overrules the demurrer to
the fifth cause of action.
              7. Causes Of Action For Breaches Of Partnership Agreement, Joint
Venture Agreement, And Fiduciary Duty
       Based on the allegations of the second amended complaint that plaintiff Sisigma
entered into an oral joint venture agreement with Quantum in August 2017, plaintiffs
assert a seventh cause of action for breach of partnership agreement, an eighth cause of
action for breach of joint venture agreement, and a ninth cause of action for breach of

                                              22
fiduciary duty arising from defendants breaching their duty as partners and joint
venturers.
       We understand plaintiffs to contend that the trial court erred in sustaining the
demurrers to these causes of action without leave to amend because the original
complaint stated facts sufficient for the contract causes of action. However, we have
previously determined, as discussed above, that the allegations in the original complaint
are insufficient to establish contract formation by ratification. We therefore also
determine that the trial court did not err in sustaining the demurrers to the seventh, eighth,
and ninth causes of action.
                                    IV. DISPOSITION
       The judgment is reversed. The trial court is directed (1) to vacate the order
sustaining the demurrers to the first through fifth and seventh through ninth causes of
action of the second amended complaint without leave to amend; and (2) to enter a new
order sustaining the demurrer without leave to amend as to the first through fourth causes
and the seventh through ninth causes of action and overruling the demurrer as to the fifth
cause of action. The parties shall bear their own costs on appeal.

                                             23
                               BAMATTRE-MANOUKIAN, J.

WE CONCUR:

GREENWOOD, P.J.

WILSON, J.

Hassan et al. v. Quantum3D, Inc.
H050403